« Vertex Urges CDC to Adopt Hep C Screening to Spur New Wave of Patients | Main | A Fork in the Road for Pharmaceuticals »

02/02/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0147e23a4889970b

Listed below are links to weblogs that reference Seattle Genetics Raises $155M to Support Selling First Drug:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

Here's more from Xconomy today (Feb 8th) on SeaGen's EOY reported cash balances.
http://www.xconomy.com/seattle/2011/02/08/seagen-expects-280m-cash-at-year-end/

bigredbruce

Xconomy reports this morning (Feb 3rd) that Seattle Genetics raised another $23 M when its underwrtiers exercised their optino to purchase shares.
http://www.xconomy.com/seattle/2011/02/03/seagen-tacks-on-23m/

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada